Haba Laboratories Inc. (4925) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Haba Laboratories Inc. (4925:JPX), powered by AI.

Current Price
¥1,710
P/E Ratio
11.2
Market Cap
6.5B
Sector
Consumer Defensive
What is the Haba Laboratories Inc. stock price forecast?

Haba Laboratories Inc. is currently trading at ¥1,710. View real-time AI analysis on Alpha Lenz.

What is Haba Laboratories Inc. insider trading activity?

View the latest insider trading data for Haba Laboratories Inc. on Alpha Lenz.

What is Haba Laboratories Inc.'s P/E ratio?

Haba Laboratories Inc.'s P/E ratio is 11.2.

Haba Laboratories Inc.

JPX · 4925
¥1,710+7(+0.41%)Market closedJPX regular session 09:00–15:00 JST
Ask about Haba Laboratories Inc.'s future dividend policy...
Alpha Chat Insight

Haba Laboratories Inc. trades at a P/E of 11.2 (undervalued) with modest ROE of 6.6%.

Ask for details

Company Overview

Haba Laboratories Inc. is a notable entity within the cosmetics and skincare industry, focusing on producing high-quality beauty products primarily in Japan. The company's core mission centers around developing hypoallergenic skincare items that are both effective and gentle, ensuring broad consumer appeal among individuals with sensitive skin concerns. Haba Laboratories Inc. places a strong emphasis on using natural ingredients, avoiding additives or coloring agents, which aligns with the increasing global demand for eco-friendly and safe personal care products. Their product line includes a variety of facial cleansers, moisturizers, and anti-aging solutions, targeting a diverse demographic seeking reliable skincare regimes. As part of the broader cosmetics sector, Haba Laboratories Inc. plays a significant role in driving innovation and maintaining consumer trust. By leveraging research and development, the company continues to enhance its product offerings, contributing to the dynamic and competitive nature of the international beauty market. Its steadfast commitment to quality and sustainability ensures that it remains a key player, capitalizing on evolving consumer preferences towards clean and conscious beauty products.

CEOIssei Miyazaki
SectorConsumer Defensive
IndustryHousehold & Personal Products
Employees568

Company Statistics

FY 2025

Profile

¥6,466,390,650Market Cap
¥12,061,829,000Revenue
0.00Shares Out
568Employees

Margins

67.09%Gross
6.51%EBITDA
4.89%Operating
5.27%Pre-Tax
4.78%Net

Valuation

11.22P/E
0.72P/B
0.54EV/Sales
4.51EV/EBITDA
4.59P/FCF

Growth (CAGR)

-2.24%Rev 3Yr
-8.07%Rev 5Yr
N/AOp Inc 3Yr
-21.66%Op Inc 5Yr
N/ANet Inc 3Yr
-15.18%Net Inc 5Yr

Returns

4.65%ROA
6.61%ROE
5.27%ROIC

Financial Health

¥4,743,538,000Cash & Cash Equivalents
¥-1,326,314,000Net Debt
38.28%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Haba Laboratories Inc. (ticker: 4925) is a company listed on JPX in the Consumer Defensive sector (Household & Personal Products). It has approximately 568 employees. Market cap is $6.5B.

The current price is 1,710 with a P/E ratio of 11.22x and P/B of 0.72x.

ROE is 6.61% and operating margin is 4.89%. Annual revenue is $12.1B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Haba Laboratories Inc. (4925) Stock Forecast 2026 ¥1,710 — Price, Financials & Analyst Targets | Alpha Lenz